Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.

The Journal of biological chemistry - 16 May 2014

Qin Yu, Fu Maoyong, Takahashi Masamichi, Iwanami Akio, Kuga Daisuke, Rao Rajiv G, Sudhakar Deepthi, Huang Tiffany, Kiyohara Meagan, Torres Kathleen, Dillard Christen, Inagaki Akihito, Kasahara Noriyuki, Goodglick Lee, Braun Jonathan, Mischel Paul S, Gordon Lynn K, Wadehra Madhuri

Abstract excerpt

Despite recent advances in molecular classification, surgery, radiotherapy, and targeted therapies, the clinical outcome of patients with malignant brain tumors remains extremely poor. In this study, we have identified the tetraspan protein epithelial membrane protein-2 (EMP2) as a potential targ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Proliferation
Share to Enzyme Activation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Focal Adhesion Kinase 1

Share to Gene Expression Regulation, Neoplastic

Share to Glioblastoma

Share to Membrane Glycoproteins

Share to Molecular Targeted Therapy

Share to src-Family Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 24644285
DOI: 10.1074/jbc.M113.543728
PMCID: PMC4022868

Genes

EMP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24644285-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.PMID 24644285Read ↗

EMP3: A promising biomarker for tumor prognosis and targeted cancer therapySemantic proximity Read ↗

EMP3 as a prognostic biomarker correlates with EMT in GBMSemantic proximity Read ↗

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastomaSemantic proximity Read ↗

Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.Semantic proximity Read ↗

Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma.Semantic proximity Read ↗

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT GlioblastomasSemantic proximity Read ↗

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axisSemantic proximity Read ↗

The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progressionSemantic proximity Read ↗

Endothelial-secreted Endocan protein acts as a PDGFR alpha ligand and regulates vascularity, radioresistance, and regional phenotype in glioblastomaSemantic proximity Read ↗

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma.Semantic proximity Read ↗

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signalingSemantic proximity Read ↗

EIF2S2 as a Prognostic Marker and Therapeutic Target in Glioblastoma: Insights into its Role and Downstream MechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.